{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:46:17Z","timestamp":1777873577575,"version":"3.51.4"},"reference-count":52,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain & Palliative Care Pharmacotherapy"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/15360288.2025.2562033","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T08:59:32Z","timestamp":1759309172000},"page":"87-99","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["The Risk of Chronic Opioid Utilization with Tramadol: A Narrative Review of the Literature"],"prefix":"10.1080","volume":"40","author":[{"given":"Eric P.","family":"Borrelli","sequence":"first","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego","place":["La Jolla, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"e_1_3_2_2_1","unstructured":"Tramadol. [package insert]. Brookhaven (NY): Amneal Pharmaceuticals of NY LLC; 2024 [cited 2025 Jan 7]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=67919c2c-2f8a-4bbb-bef5-0cd6c1e63a16."},{"issue":"127","key":"e_1_3_2_3_1","first-page":"37623","article-title":"Schedules of controlled substances: placement of tramadol into schedule IV","volume":"79","author":"United States Federal Register","year":"2014","unstructured":"United States Federal Register. Schedules of controlled substances: placement of tramadol into schedule IV. U S Fed Reg. 2014;79(127):37623\u201330. Available from: https:\/\/www.govinfo.gov\/content\/pkg\/FR-2014-07-02\/pdf\/2014-15548.pdf [cited Jan 4 2025].","journal-title":". U S Fed Reg"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.3386\/w27520"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc25-S012"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000013038"},{"issue":"3","key":"e_1_3_2_7_1","first-page":"227","article-title":"Treating painful diabetic peripheral neuropathy: n update","volume":"94","author":"Snyder MJ","year":"2016","unstructured":"Snyder MJ, Gibbs LM, Lindsay TJ. Treating painful diabetic peripheral neuropathy: n update. Am Fam Physician. 2016;94(3):227\u201334.","journal-title":"Am Fam Physician"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.01399"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41142"},{"key":"e_1_3_2_10_1","unstructured":"American Academy of Orthopaedic Surgeons Management of Osteoarthritis of the Knee (Non-Arthroplasty) Evidence-Based Clinical Practice Guideline. American Academy of Orthopaedic Surgeons. 2021 Aug 31 [cited May 13 2025]. Available from: https:\/\/www.aaos.org\/globalassets\/quality-and-practice-resources\/osteoarthritis-of-the-knee\/oak3cpg.pdf."},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2367"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/L23-0043"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.12.026"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.11390"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-019-0777-x"},{"issue":"135","key":"e_1_3_2_16_1","first-page":"1","article-title":"Trends in opioids prescribed at discharge from emergency departments among adults: United States, 2006\u20132017","author":"Rui P","year":"2020","unstructured":"Rui P, Santo L, Ashman JJ. Trends in opioids prescribed at discharge from emergency departments among adults: United States, 2006\u20132017. Natl Health Stat Report. 2020;(135):1\u201312.","journal-title":"Natl Health Stat Report"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2024.06.009"},{"issue":"5","key":"e_1_3_2_18_1","first-page":"33","article-title":"Assessing the trends of tramadol utilization in the medicare part D population in Rhode Island","volume":"107","author":"Borrelli EP.","year":"2024","unstructured":"Borrelli EP. Assessing the trends of tramadol utilization in the medicare part D population in Rhode Island. R I Med J (2013). 2024;107(5):33\u20137.","journal-title":"R I Med J (2013)"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18943"},{"issue":"4","key":"e_1_3_2_20_1","first-page":"533","article-title":"Serotonin syndrome","volume":"13","author":"Volpi-Abadie J","year":"2013","unstructured":"Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J. 2013;13(4):533\u201340.","journal-title":"Ochsner J"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.neuropsych.11110343"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.892264"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/0897190013504957"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18372"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000001683"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026705"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-011-0168-0"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40267-021-00859-6"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000001075"},{"key":"e_1_3_2_30_1","unstructured":"ClinCalc. The Top 300 of 2022. ClinCalc. 2025 [cited Jan 10 2025]. Available from: https:\/\/clincalc.com\/DrugStats\/Top300Drugs.aspx."},{"key":"e_1_3_2_31_1","article-title":"Tramadol is not opioid-lite","volume":"365","author":"Stannard C.","year":"2019","unstructured":"Stannard C. Tramadol is not opioid-lite. BMJ. 2019;365.","journal-title":"BMJ"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.17161\/kjm.vol1413513"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6610a1"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gerinurse.2018.10.003"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2021.07.018"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l1849"},{"issue":"1","key":"e_1_3_2_37_1","first-page":"12","article-title":"Predictors of transitioning to incident chronic opioid therapy among working-age adults in the united states","volume":"11","author":"Thornton JD","year":"2018","unstructured":"Thornton JD, Dwibedi N, Scott V, Ponte CD, Ziedonis D, Sambamoorthi N, Sambamoorthi U. Predictors of transitioning to incident chronic opioid therapy among working-age adults in the united states. Am Health Drug Benefits. 2018;11(1):12\u201321.","journal-title":"Am Health Drug Benefits"},{"issue":"3","key":"e_1_3_2_38_1","first-page":"e222","article-title":"Treatment patterns, healthcare utilization, and costs of chronic opioid treatment for non-cancer pain in the United States","volume":"21","author":"Kern DM","year":"2015","unstructured":"Kern DM, Zhou S, Chavoshi S, Tunceli O, Sostek M, Singer J, LoCasale RJ. Treatment patterns, healthcare utilization, and costs of chronic opioid treatment for non-cancer pain in the United States. Am J Manag Care. 2015;21(3):e222\u2013e234.","journal-title":"Am J Manag Care"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8847777"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.15255"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnad169"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.28159"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2020.01.055"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.sart.2020.10.012"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1178221820930006"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2005.10.006"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002300"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2017.10.060"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e318169d03b"},{"key":"e_1_3_2_51_1","unstructured":"Nucynta ER. (tapentadol hydrochloride) [package insert]. Stoughton (MA): Collegium Pharmaceutical Inc; 2023 [cited 2025 Jan 7]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=c3d04d70-0155-4147-9ce4-a3b1fad4b373."},{"key":"e_1_3_2_52_1","first-page":"30726003","volume-title":"StatPearls [Internet]","author":"Preuss CV","year":"2023","unstructured":"Preuss CV, Kalava A, King KC. Prescription of controlled substances: benefits and risks. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. p. 30726003."},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2023.0781"}],"container-title":["Journal of Pain & Palliative Care Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15360288.2025.2562033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:04:15Z","timestamp":1777572255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15360288.2025.2562033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/15360288.2025.2562033"],"URL":"https:\/\/doi.org\/10.1080\/15360288.2025.2562033","relation":{},"ISSN":["1536-0288","1536-0539"],"issn-type":[{"value":"1536-0288","type":"print"},{"value":"1536-0539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-10","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}